Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
By 2032, the Cell Harvesting Market should be worth USD 9.93 billion, thanks to a growth rate of 11% per year. The Cell Harvesting Market is shaped and grown by a number of factors. Therapies based on cells and regenerative medicine are two of the main forces. As regenerative medicine gets better, we need cell collection methods that work well and quickly. To do stem cell studies, cell therapies, and tissue engineering, you need to collect cells.
The Cell Harvesting Market is shaped by changes in technology. Methods of collecting cells mechanically, enzymatically, and automatically are being improved to make them more accurate and productive. High-tech methods separate certain types of cells without hurting them, which keeps cells alive and working. Robots and automation make cell collection faster and more consistent in medical and study settings.
The Cell Harvesting Market is affected by the growth of stem cell research and its possible uses in medicine. Stem cells are used in regenerative medicine because they can change into different types of cells.
Cell-based therapies may be able to help heart, brain, and joint problems. Autologous therapy using harvested cells from a patient reduces the risk of immune rejection and makes treatment more personalized. Point-of-care cell harvesting tools make it easier for people in hospital situations to get cell-based medicines.
The Cell Harvesting Market is greatly affected by government funds and rules. Funding from the government for stem cell research and regenerative medicine makes it easier to get cells. To make sure that cell-based treatment is safe and effective, regulatory systems need to test and standardize cell collection technologies. For cell-based products to be approved and sold, regulations must be followed.
Cost-effectiveness and the ability to grow are two economic factors that affect how widely cell harvesting technology is used. For cell collection tools to be widely used in study and therapy, they need to be able to make money. Biopharmaceutical companies and academic research labs that make a lot of cell-based medicines need gathering methods that are both scalable and affordable.
The Cell Harvesting Market grows when people around the world work together and share knowledge. Researchers, healthcare organizations, and business people all share what they know about cell harvesting and the best ways to do it. International teamwork is needed to deal with different cell sources, improve gathering methods, and make processes more consistent. Since scientists all over the world work together, new discoveries are benefited by many points of view and uses.
The Cell Harvesting Market is shaped by competition and mergers. Market competition is sparked by established companies, newbies, and smart partnerships. Through mergers and purchases, companies can expand their product lines, reach new markets, and become more competitive in the field of cell harvesting technology, which is always changing. Competition drives new product development, low prices, and easy access to cell harvesting solutions.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Growth Rate | 11% |
Cell Harvesting Market Highlights:
Global Cell Harvesting Market Overview
Cell Harvesting Market Size was valued at USD 5.78 Billion in 2023. The Global Cell Harvesting industry is projected to grow from USD 5.89 Billion in 2024 to USD 10.34 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.9% during the forecast period (2024 - 2032). Cell harvesting involves separating the cell culture from the growth media using procedures including centrifugation, microfiltration, and depth filtration.
Numerous reasons, including an increase in chronic illnesses and disorders, rapid expansions in the biotechnology and pharmaceutical sectors, and increased research in regenerative treatments, are projected to boost the cell harvesting industry. Furthermore, the cost-effectiveness, convenience of use, and durability of harvesters, as well as technical breakthroughs and design improvement of cell harvester devices, drive the cell harvesting market's growth. Several corporations are also launching new products to boost their market position.
In December 2023, Cheetah Prime- A PerkinElmer Inc. project- will be demonstrated, shaped as an automated closed system letting out a chance of the sterile separation of different types of cells. Fat cell grabber machine is an advanced technology that aims at increasing the number and viability of cells.
In November 2023 indicated that Argos Technologies Inc. had entered into an agreement with a leading European research institute to carry out clinical trials on their sophisticated fat cell grabber machine (fat cell harvester), which could increase both numbers and viability of obtained cells.
In October 2023, Terumo Corporation bought Athersys, Inc., a firm involved in developing cellular therapy techniques, so as to get access to Athersys adipose-derived stem cell platform that might be integrated into Terumo’s cell harvesting devices.
CliniMACS Prodigy platform was launched by Miltenyi Biotec in the month of October 2023 as it sported an automated workflow for isolating and enriching cells from various sources making it ideal for R&D-related cellular therapies.
For instance, Orgenesis invested $50 million into Morgenesis after receiving FDA approval for its point-of-care autologous cell therapy product.
As an illustration, researchers at the University of Technology Sydney (UTS) came up with this idea along with Regeneus biotech company in June 2022, printed on a 3D printer microfluidic stem-cell harvesting system. In fact, it is a simple and cheap device that can trap stem cells escaping from bioreactor systems, facilitating cost-effective and scalable process control.
In March 2022 Stem Cell Therapies (SCT) Mission allocated $150 million to novel therapies that are safe, effective and accessible, thereby enhancing better health outcomes involving the patients as well as carers—Australian Government Department of Health and Aged Care said. Thereby, this mission funds projects to develop new therapies that are safe and effective for patients, to develop the workforce capacity, as well as translate stem cell innovations into commercial products.
However, the technical complexity of harvesters, coupled with ethical issues related to embryonic stem cell research may curb the growth of the cell harvesting market. Stringent government regulations and mandatory licensing rules may also hamper the market growth during the assessment period.
Cell Harvesting Market Segment Insights
The cell harvesting market has been segmented into product type, application, and end user.
Cell Harvesting Product Type Insights
The cell harvesting market, on the basis of product type, has been segmented into manual cell harvesters and automated cell harvesters.
The manual cell harvesters segment is estimated to hold the largest share owing to the high preferability of manual cell harvesters, whereas the automated cell harvesters segment is expected to be the fastest growing segment due to increased awareness and rise in the use of automated technologies in devices.
Cell Harvesting Application Insights
The cell harvesting market, by application, has been segmented into biopharmaceutical application, stem cell research, and others.
Cell Harvesting End User Insights
The cell harvesting market, by end user, has been segmented into pharmaceutical companies, biotechnology companies, research institutes, and others.
Cell Harvesting Regional Insights
The cell harvesting market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Geographically, the Americas is anticipated to dominate the cell harvesting market owing to a well-developed healthcare sector and growing healthcare expenditure. For instance, according to the data published by the Committee for a Responsible Federal Budget in May 2018, the US spent about USD 3.5 trillion, or 18% of its Gross Domestic Product (GDP) on health expenditures, which accounted for more than twice the average among developed countries in 2017. Additionally, many companies in this region focus on the innovation of new treatment options, thus being a lucrative option for the growth of the cell harvesting market in this region.
Europe is expected to hold the second largest position in the cell harvesting market. The market growth in this region owes to the availability of funds for research. For instance, according to the data published by the National Institute of Health Funding (NIHR) in 2016, funding of EUR 928 million was announced for new NIHR Biomedical Research Centers (BRC) and NIHR Clinical Research Facilities (CRF) for five years starting from April 2017.
Asia-Pacific is anticipated to be the fastest growing region in the cell harvesting market due to the presence of a huge patient population and continuously developing economies.
On the other hand, the Middle East and Africa has the least share of the market. The majority of the market of this region is expected to be held by the Middle Eastern region due to growing government initiatives for the healthcare sector.
Cell Harvesting Market Key players
- ads-tec GmbH
- Argos Technologies, Inc.
- Arthrex, Inc.
- Avita Medical
- Bertin
- connectorate
- Cox Scientific
- hynoDent AG
- PerkinElmer Inc.
- Scinomix
- Teleflex Incorporated
- TERUMO CORPORATION
Cell Harvesting Market Segmentation
Cell Harvesting Product Type Outlook
- Manual Cell Harvesters
- Automated Cell Harvesters
Cell Harvesting Application Outlook
- Biopharmaceutical Application
- Stem Cell Research
- Others
Cell Harvesting End User Outlook
- Pharmaceutical Companies
- Biotechnology Companies
- Research Institutes
- Others
Cell Harvesting Region Outlook
- Americas
- North America
- US
- Canada
- South America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
The report for Cell Harvesting Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Recent Development
ADS-TEC is a producer and provider of high-quality, long-lasting Industrial IT systems, as well as high-performance battery systems and full storage solutions. ADS-in-house TEC's development is characterized by over 35 years of experience and professional skill in system development. ADS-TEC, a medium-sized company, employs around 240 people at two locations in Germany. The headquarters were transferred from Leinfelden-Echterdingen to a new facility in Nuertingen, near Stuttgart, in May 2014. The headquarters are supplemented by a manufacturing facility in Wilsdruff, near Dresden.
Argos Technologies delivers one-of-a-kind equipment and materials to help life scientists improve science. We stock the whole Argos Technologies product range, including the famous PolarSafe® products, for liquid handling, microbiology, cell biology, general laboratory, tabletop equipment, and cryogenic storage. Cryogenic storage racks and boxes, cryogenic vials and caps, upright freezer racks, labels, pipettes, pipette controllers, cell spreaders, mini centrifuges, centrifuge tubes, tube rotators, and other items are available in Agro technologies.
Intended Audience
- Pharmaceutical companies
- Biotechnology companies
- Cell harvester vendors
- Research and Development (R&D) companies
- Government research institutes
- Academic institutes and universities
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
